Results 91 to 100 of about 131,929 (338)

Five immune‐gene‐signatures participate in the development and pathogenesis of Kawasaki disease

Immunity, Inflammation and Disease, 2021
Objective To screen for immune genes that play a major role in Kawasaki disease and to investigate the pathogenesis of Kawasaki disease through bioinformatics analysis.
Han Nie, Shizhi Wang, Quanli Wu, Danni Xue, Weimin Zhou   +4 more
doaj   +1 more source

Well-posedness of the Dean--Kawasaki and the nonlinear Dawson--Watanabe equation with correlated noise [PDF]

arXiv, 2021
In this paper we prove the well-posedness of the generalized Dean--Kawasaki equation driven by noise that is white in time and colored in space. The results treat diffusion coefficients that are only locally 1/2-H\"older continuous, including the square root. This solves several open problems, including the well-posedness of the Dean--Kawasaki equation
arxiv  

Hospitalisation with Infection, Asthma and Allergy in Kawasaki Disease Patients and Their Families: Genealogical Analysis Using Linked Population Data [PDF]

, 2011
Background: Kawasaki disease results from an abnormal immunological response to one or more infectious triggers. We hypothesised that heritable differences in immune responses in Kawasaki disease-affected children and their families would result in ...
A Elixhauser, A Harnden, A Read, AH Rowley, AL Baker, Angeline M. Loh, CD Holman, CL Brosius, D Burgner, D Burgner, David P. Burgner, DL Worthley, EJ Glasson, ES Selamet Tierney, FJ Stanley, FJ Tsai, HC Kuo, IR Mackay, J Kimura, JA Royle, JC Burns, JJ Kim, JM Anaya, JW Newburger, K Ding, Kim W. Carter, KS Carville, LM Maier, Lyle J. Palmer, Marie-Pierre Dubé, MH Biezeveld, MH Biezeveld, MP Glode, N Chahal, Nicole M. Warrington, NM Nielsen, PC Sham, R Ihaka, R Uehara, RC Gualano, RC Holman, Rebecca J. Webster, RR Dietert, S Matsuoka, S Sato, SM Benseler, Sophie Zaloumis, T Matsubara, Taco W. Kuijpers, TW Kuijpers, V Gee, WK Liew, Y Fujita, Y Onouchi, Y Shikishima, YF Cheung   +55 more
core   +4 more sources

Acute myocarditis according to age: Presentation, management and early outcomes

ESC Heart Failure, EarlyView.
MIS, multisystem inflammatory syndrome; MRE, myocarditis‐related events (within 30 days included all‐cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block). Abstract Aims Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are
Clément Karsenty, Paul Vignaud, Clara Brusq, Pamela Moceri, Pascal Lim, Edouard Gerbaud, Olivier Lairez, Coline Lelarge, Caroline Ovaert, Claire Bouleti, Oscar Werner, Vanina Bongard, Thibaud Genet, Laurent Bonnemains, Christophe Tron, Elise Barre, Margaux Boddaert, Jacques Mansourati, Chérine Benzouid, François Roubille, Hadi Khachab, Sabrina Uhry, Ariel Cohen, Benoit Lattuca, Sylvie Di Filippo, Clément Delmas   +25 more
wiley   +1 more source

A Tale of a Trail on How It Takes 5 Days of Kawasaki Disease to Initiate Coronary Artery Injury and Change the Lives of Children

Turkish Archives of Pediatrics
Many articles written on Kawasaki disease explain the disease and the history of an acute inflammatory dysregulation that typically affects preschool children and does not spare older ones.
Nagib Dahdah
doaj   +1 more source

Kawasaki disease in Hong Kong, 1994 to 2000 [PDF]

, 2005
OBJECTIVE. To describe the epidemiology, clinical characteristics, and management of Kawasaki disease in children in Hong Kong. DESIGN. Retrospective survey of medical records from July 1994 to June 1997, and prospective data collection from July 1997 to
Cheng, YW, Chiu, WK, Fong, NC, Ho, MHK, Kwok, KL, Lee, SH, Mak, WC, Ng, YM, So, LY, Sung, RYT, Wong, DML, Yam, MC   +11 more
core  

Catheter Interventions for Kawasaki Disease: Current Concepts and Future Directions [PDF]

, 2011
During the past 15 years, clinical experience with catheter interventional treatment in patients with Kawasaki disease, including balloon angioplasty, stent implantation, rotational ablation, and transluminal coronary revascularization, has been ...
Akagi, Teiji
core   +2 more sources

History of the worldwide emergence of Kawasaki disease [PDF]

, 2017
Dr. Kawasaki saw his first case of the disease that would come to bear his name in 1961. His meticulous description of the clinical syndrome persists as the case definition to the present day.
Burns, Jane C
core   +1 more source

Tomisaku Kawasaki and Kawasaki disease [PDF]

Child's Nervous System, 2020
Steven H. Yale, Halil Tekiner, Eileen S. Yale   +2 more
openaire   +4 more sources

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source